πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,315 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8097610

Derivative having PPAR agonistic activity

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8093354

Process for preparing glycopeptide phosphonate derivatives

Theravance, Inc. Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088365

Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound mo

Nektar Therapeutics Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084016

Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessi

The Regents of the University of California Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084058

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8076352

Administration of carboline derivatives useful in the treatment of cancer and other diseas

PTC THERAPEUTICS, INC. Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071603

Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

Xenon Pharmaceuticals Inc. Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071535

Guanidinium derivatives for improved cellular transport

The Regents of the University of California Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8063057

Multicyclic amino acid derivatives and methods of their use

LEXICON PHARMACEUTICALS, INC. Β· Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8049016

Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes

Xenon Pharmaceuticals Inc. Β· Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044236

Carboxilic acid derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044033

Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044049

Fused heterocyclic derivative and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034812

Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent th

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030488

Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic

Xenon Pharmaceuticals Inc. Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030307

Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 pr

Enanta Pharmaceuticals, Inc. Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030445

Glycopeptide derivative

Theravance, Inc. Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030341

Dmt-derivative compounds and related compositions and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8026284

Enterically coated cystamine, cysteamine and derivatives thereof

The Regents of the University of California Β· Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017149

Modified release preparations containing oxcarbazepine and derivatives thereof

Supernus Pharmaceuticals, Inc. Β· Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003755

Hydrochloride salts of a glycopeptide phosphonate derivative

Theravance, Inc. Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003742

Polymer derivatives with proximal reactive groups

Nektar Therapeutics Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003629

21-substituted progesterone derivatives as new antiprogestational agents

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998992

Oxazolidinone derivative having inhibitory activity on 11Ξ²-hydroxysteroid dehydrogenase ty

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted